Keywords: European Union, EFPIA, Innovative Medicines Iniative, Research

Three high profile leaders in pharma sector join EU's Innovative Medicines Initiative governing board

Article | 19 May 2010

Roch Doliveux, chief executive of the Belgian biopharmaceutical company UCB, has joined the governing board of the Innovative Medicines Initiative ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in